Page last updated: 2024-08-25

methotrexate and Opsoclonus-Myoclonus Syndrome

methotrexate has been researched along with Opsoclonus-Myoclonus Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Engel, WK; Gilles, E; Ketterl, TG; Messinger, YH; Niess, DR; Perkins, JL	1

Other Studies

1 other study(ies) available for methotrexate and Opsoclonus-Myoclonus Syndrome

Article	Year
Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma. Pediatric blood & cancer, 2013, Volume: 60, Issue:12 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoantigens; ELAV Proteins; Female; Humans; Infant; Mediastinal Neoplasms; Methotrexate; Neuroblastoma; Opsoclonus-Myoclonus Syndrome	2013

Article

Year

Ofatumumab for refractory opsoclonus-myoclonus syndrome following treatment of neuroblastoma.

Pediatric blood & cancer, 2013, Volume: 60, Issue:12

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Autoantigens; ELAV Proteins; Female; Humans; Infant; Mediastinal Neoplasms; Methotrexate; Neuroblastoma; Opsoclonus-Myoclonus Syndrome

2013